Evidence map›Paper›PMID 41945616›Full record

ArticlePLoS pathogens2026

GM-CSF orchestrates monocyte and granulocyte responses to Cryptococcus gattii.

Alison Ricafrente, Sreemoyee Acharya, Shuyi Chen, Adiza Abass, Aelita Arshakyan, Tyler J Olson, Apurwa Trivedi, Lena J Heung

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. TREM2 drives monocyte-derived macrophage responses tobioRxiv : the preprint server for biology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alison RicafrenteDepartment of Medicine, Women's Guild Lung Institute, Cedars-Sinai Health Sciences University, Los Angeles, California, United States of America.
Sreemoyee AcharyaDepartment of Medicine, Women's Guild Lung Institute, Cedars-Sinai Health Sciences University, Los Angeles, California, United States of America.
Shuyi ChenDepartment of Medicine, Women's Guild Lung Institute, Cedars-Sinai Health Sciences University, Los Angeles, California, United States of America.
Adiza AbassDepartment of Medicine, Women's Guild Lung Institute, Cedars-Sinai Health Sciences University, Los Angeles, California, United States of America.
Aelita ArshakyanDepartment of Medicine, Women's Guild Lung Institute, Cedars-Sinai Health Sciences University, Los Angeles, California, United States of America.
Tyler J OlsonDepartment of Medicine, Women's Guild Lung Institute, Cedars-Sinai Health Sciences University, Los Angeles, California, United States of America.
Apurwa TrivediDepartment of Medicine, Women's Guild Lung Institute, Cedars-Sinai Health Sciences University, Los Angeles, California, United States of America.
Lena J HeungDepartment of Medicine, Women's Guild Lung Institute, Cedars-Sinai Health Sciences University, Los Angeles, California, United States of America.ORCID 0000-0002-6655-575X

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
DAP12 and the host response to cryptococcosisR01AI162765 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI HEUNG, LENA J · 2021 to 2025
$2.8M
Multidisciplinary Pulmonary Research Training ProgramT32HL170963 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI PETER CHEN · 2024 to 2026
$986k
Inflammatory monocytes and host control of cryptococcosisK08AI130366 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI HEUNG, LENA J · 2017 to 2021
$829k
NCATS NIH HHS UL1 TR001881NHLBI NIH HHS T32 HL170963NIAID NIH HHS K08 AI130366NIAID NIH HHS R01 AI162765
6 · The paper itself

Abstract

Cryptococcus gattii is an emerging fungal pathogen that is acquired through the respiratory tract and causes invasive infections in both immunocompromised and otherwise healthy people. Many of these apparently immunocompetent patients are subsequently found to have autoantibodies against the pleiotropic cytokine GM-CSF. In this study, we investigated the potential role of GM-CSF (or CSF2) in the host response to C. gattii using a murine model of infection. Interestingly, infected Csf2-/- mice were found to have significantly improved survival and decreased lung fungal burden compared to wild type (WT) mice. We determined that during C. gattii infection, GM-CSF promotes the differentiation of monocytes into alveolar and interstitial macrophages. When these macrophages are ablated in CCR2-DTR+ mice, there is a corresponding improvement in survival with decreased lung fungal burden, thus phenocopying Csf2-/- mice. WT bone-marrow derived macrophages challenged with C. gattii and interstitial and alveolar macrophages from infected WT mice are unable to undergo M1 polarization, suggesting that monocyte-derived macrophages (moMacs) are rendered permissive for fungal proliferation. Therefore, GM-CSF and moMacs mediate immune responses that are harmful to the host. We further found that GM-CSF and moMacs preferentially promote the influx of eosinophils over neutrophils into the infected lung which is associated with substantial inflammatory lung pathology. Ablation of neutrophils using Mrp8cretg iDTR+ mice significantly increased C. gattii burden in the lungs, indicating that GM-CSF and moMacs block the entry of these beneficial, fungal-clearing granulocytes during infection. Altogether, our results show that GM-CSF plays a key role in impeding host anti-fungal responses to C. gattii by coordinating monocyte-derived macrophages and granulocyte activity and crosstalk.

Indexed as

CryptococcosisCryptococcus gattiiGranulocyte-Macrophage Colony-Stimulating FactorGranulocytesMonocytesAnimalsLungMacrophagesMacrophages, AlveolarMiceMice, Inbred C57BLMice, KnockoutGranulocyte-Macrophage Colony-Stimulating Factor

Identifiers

PMID41945616
PMCPMC13068330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.